Tolazoline Hydrochloride
Generic Name: tolazoline hydrochloride
Manufactured by NOVARTIS. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: TOLAZOLINE HYDROCHLORIDE (25MG/ML). Application: NDA006403.
Overview
Manufactured by NOVARTIS. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: TOLAZOLINE HYDROCHLORIDE (25MG/ML). Application: NDA006403.
Dosage
Available as injectable for injection use.
Related Medications
Bromfenac Ophthalmic Solution 0.09%
bromfenac ophthalmic solution 0.09%
11 DESCRIPTION Bromfenac ophthalmic solution 0.09% is a sterile, topical, nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Each mL of bromfenac ophthalmic solution contains 1.035 mg bromfenac sodium (equivalent to 0.9 mg bromfenac free acid). Bromfenac sodium is designated chemically as sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate, with an empirical formula of C 15 H 11 BrNNaO 3 • 3/2 H 2 O.
Orphenadrine Citrate, Aspirin And Caffeine
orphenadrine citrate, aspirin and caffeine
Nonsteroidal Anti-inflammatory Drug [EPC]
DESCRIPTION Each Norgesic TM Tablet, for oral administration contains Orphenadrine Citrate 25 mg, Aspirin 385 mg and Caffeine 30 mg. In addition, each tablet contains the following inactive ingredients: anhydrous lactose, colloidal silicon dioxide, D&C yellow #10, FD&C blue #1, zinc stearate, povidone, pregelatinized starch, and stearic acid. Orphenadrine citrate is (2-dimethylaminoethyl 2-methylbenzhydryl ether citrate).
Koeleria Cristata
koeleria cristata
Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: KOELERIA MACRANTHA POLLEN (.05 g/mL). Category: BLA.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.